Simon de Lusignan1,2, Helen Alexander3, Conor Broderick3, John Dennis4, Andrew McGovern4, Clarie Feeney5, Carsten Flohr3. 1. Nuffield Department of Primary Care health Sciences, University of Oxford, Oxford, UK. 2. Royal College of General Practitioners, Research and Surveillance Centre, London, UK. 3. Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust and King's College London, London, UK. 4. Momentum Data, Pendragon House, St. Albans, UK. 5. Pfizer Ltd, Tadworth, UK.
Abstract
BACKGROUND: Despite the high disease burden of eczema, a contemporary overview of the patterns and trends in primary care healthcare utilization and treatment is lacking. OBJECTIVE: To quantify primary care consultations, specialist referrals, prescribing, and treatment escalation, in children and adults with eczema in England. METHODS: A large primary care research database was used to examine healthcare and treatment utilization in people with active eczema (n = 411,931). Management trends and variations by age, sex, socioeconomic status, and ethnicity were described from 2009 to 2018 inclusive. RESULTS: Primary care consultation rates increased from 87.8 (95% confidence interval [95% CI] 87.3-88.3) to 112.0 (95% CI 111.5-112.6) per 100 person-years over 2009 to 2018. Specialist referral rates also increased from 3.8 (95% CI 3.7-3.9) to 5.0 (95% CI 4.9-5.1) per 100 person-years over the same period. Consultation rates were highest in infants. Specialist referrals were greatest in the over 50s and lowest in people of lower socioeconomic status, despite a higher rate of primary care consultations. There were small changes in prescribing over time; emollients increased (prescribed to 48.5% of people with active eczema in 2009 compared to 51.4% in 2018) and topical corticosteroids decreased (57.3%-52.0%). Prescribing disparities were observed, including less prescribing of potent and very potent topical corticosteroids in non-white ethnicities and people of lower socioeconomic status. Treatment escalation was more common with increasing age and in children of non-white ethnicity. CONCLUSION AND CLINICAL RELEVANCE: The management of eczema varies by sociodemographic status in England, with lower rates of specialist referral in people from more-deprived backgrounds. There are different patterns of healthcare utilization, treatment, and treatment escalation in people of non-white ethnicity and of more-deprived backgrounds.
BACKGROUND: Despite the high disease burden of eczema, a contemporary overview of the patterns and trends in primary care healthcare utilization and treatment is lacking. OBJECTIVE: To quantify primary care consultations, specialist referrals, prescribing, and treatment escalation, in children and adults with eczema in England. METHODS: A large primary care research database was used to examine healthcare and treatment utilization in people with active eczema (n = 411,931). Management trends and variations by age, sex, socioeconomic status, and ethnicity were described from 2009 to 2018 inclusive. RESULTS: Primary care consultation rates increased from 87.8 (95% confidence interval [95% CI] 87.3-88.3) to 112.0 (95% CI 111.5-112.6) per 100 person-years over 2009 to 2018. Specialist referral rates also increased from 3.8 (95% CI 3.7-3.9) to 5.0 (95% CI 4.9-5.1) per 100 person-years over the same period. Consultation rates were highest in infants. Specialist referrals were greatest in the over 50s and lowest in people of lower socioeconomic status, despite a higher rate of primary care consultations. There were small changes in prescribing over time; emollients increased (prescribed to 48.5% of people with active eczema in 2009 compared to 51.4% in 2018) and topical corticosteroids decreased (57.3%-52.0%). Prescribing disparities were observed, including less prescribing of potent and very potent topical corticosteroids in non-white ethnicities and people of lower socioeconomic status. Treatment escalation was more common with increasing age and in children of non-white ethnicity. CONCLUSION AND CLINICAL RELEVANCE: The management of eczema varies by sociodemographic status in England, with lower rates of specialist referral in people from more-deprived backgrounds. There are different patterns of healthcare utilization, treatment, and treatment escalation in people of non-white ethnicity and of more-deprived backgrounds.
Authors: Florence J Dalgard; Uwe Gieler; Lucia Tomas-Aragones; Lars Lien; Francoise Poot; Gregor B E Jemec; Laurent Misery; Csanad Szabo; Dennis Linder; Francesca Sampogna; Andrea W M Evers; Jon Anders Halvorsen; Flora Balieva; Jacek Szepietowski; Dmitry Romanov; Servando E Marron; Ilknur K Altunay; Andrew Y Finlay; Sam S Salek; Jörg Kupfer Journal: J Invest Dermatol Date: 2014-12-18 Impact factor: 8.551
Authors: Sally A Stapley; Greg P Rubin; Deborah Alsina; Elizabeth A Shephard; Matthew D Rutter; William T Hamilton Journal: Br J Gen Pract Date: 2017-03-27 Impact factor: 5.386
Authors: Sangeeta Marwaha; Jennifer R Dusendang; Stacey E Alexeeff; Eileen Crowley; Michael Haiman; Ngoc Pham; Melanie J Tuerk; Danny Wudka; Michael Hartmann; Lisa J Herrinton Journal: Perm J Date: 2021-12-13
Authors: L von Kobyletzki; N Ballardini; D Henrohn; M P Neary; G Ortsäter; K Geale; A Rieem Dun; I Lindberg; A De Geer; P Neregård; A Cha; J C Cappelleri; W Romero; J P Thyssen Journal: J Eur Acad Dermatol Venereol Date: 2022-05-18 Impact factor: 9.228
Authors: M Harries; A E Macbeth; S Holmes; W S Chiu; W R Gallardo; M Nijher; S de Lusignan; C Tziotzios; A G Messenger Journal: Br J Dermatol Date: 2021-10-21 Impact factor: 11.113
Authors: Simon de Lusignan; Helen Alexander; Conor Broderick; John Dennis; Andrew McGovern; Clarie Feeney; Carsten Flohr Journal: Clin Exp Allergy Date: 2020-11-23 Impact factor: 5.018